Announcement by Lingkang Pharmaceutical Group Corporation on the Passing of the Injectable Cefotaxime Sodium of Its Subsidiary Through the Generic Drug Consistency Evaluation

Update: 29 October, 2023

Lingkang Pharmaceutical Injectable Cefotaxime Sodium Passed the Generic Drug Consistency Evaluation


File format: PDF

Size: -

MD5 Checksum: 23FB0FE7135DBFDD7216706B5C7282FF

Publication date: 29 October, 2023

Downloads: -

PDF Link: Announcement by Lingkang Pharmaceutical Group Corporation on the Passing of the Injectable Cefotaxime Sodium of Its Subsidiary Through the Generic Drug Consistency Evaluation PDF

Also Manuals